What happened
The Indian Pharmacopoeia Commission (IPC) signed and renewed two Memoranda of Understanding (MoUs) to deepen collaboration in healthcare quality and innovation.
IPC renewed its collaboration with CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) and signed a new collaboration with Dr. Shakuntala Misra National Rehabilitation University (DSMNRU), Lucknow. IPC stated that the collaborations aim to strengthen research, quality standards, and institutional linkages.
Background and earlier position
IPC is an institutional actor in pharmaceutical standards-related scientific work under the Ministry of Health and Family Welfare. Collaboration with research institutions such as CSIR can support specialised domains like medicinal plant research and quality evaluation. For assistive devices and inclusive safety communication, partnerships with rehabilitation and disability-focused universities support development of assessment protocols and accessible pharmacovigilance training.
What changed now
Related current affairs
- Digital market access and quality assurance measures for AYUSH drugs
- ‘No new H1N1 strain in India, existing vaccines sufficient’
- Nadda reviews preparedness, calls for robust surveillance as H1N1 cases rise in Delhi
- Faith healing poses challenge to authorities as diseases kill 7 tribal children in Madhya Pradesh
- Higher education faces three urgent challenges
- Dementia risks you can change